What is metabolic flexibility?
Metabolic flexibility is the capacity to shift between carbohydrate and lipid oxidation in response to nutrient availability. This page summarises laboratory and clinical research on its measurement, mechanisms and modif
Metabolic flexibility (MetFlex) is the capacity to shift between carbohydrate and lipid oxidation in response to nutrient availability [2]. In the research literature it is assessed as a physiological response variable rather than a single molecule: studies pair whole-room indirect calorimetry with mitochondrial respirometry, or measure the postprandial response to a high-fat test meal, to quantify how readily substrate use changes when fuel supply changes [1][2].
The work centres on mitochondrial substrate-handling pathways, including the AMPK–PGC-1α–SIRT3 axis and the sirtuin (SIRT1/SIRT3) family, which are studied for their roles in mitochondrial biogenesis, energy expenditure, oxidative metabolism and insulin sensitivity [6][8].
Research Studies
Metabolic flexibility and extreme obesity (BMI ≥60 kg/m²)
A clinical study is evaluating energy metabolism (expenditure and fat oxidation) and metabolic flexibility in response to a high-fat test meal in 10 individuals with a BMI ≥60 kg/m², using gold-standard assessments of energy metabolism, metabolic flexibility and body composition. Males and females aged 18–80 years are recruited from Baton Rouge, Louisiana; exclusion criteria include major organ failure, uncontrolled endocrine disease, severe psychiatric illness, pregnancy, and inability to comply with study procedures. Total participation is estimated at approximately 10 days [1].
Whole grape polyphenols and postprandial substrate shift
Obesity is associated with reduced metabolic flexibility [2]. Grape polyphenols (resveratrol, catechins, quercetin, epicatechin) enhance fat oxidation and mitochondrial function in laboratory and animal studies, but whole grapes, rather than purified extracts, have not been tested for acute effects on MetFlex measured directly by whole-room calorimetry paired with mitochondrial function. A trial integrates whole-room indirect calorimetry with high-resolution respirometry in peripheral blood mononuclear cells (PBMCs) to determine whether whole grape polyphenols shift the postprandial response [2].
Mediterranean diet, metabolomics and cognition in mild cognitive impairment
In a 24-week intervention, changes in metabolomics profiles were analysed to assess the effects of a Mediterranean diet (MD), with and without probiotics, and a low-fat diet (according to World Health Organization recommendations) in 47 older adults (aged ≥60 years, 42.6% women) with mild cognitive impairment (MCI). The plasma metabolome was analysed using a quantitative LC-MS/MS targeted assay, and multivariate methods were employed to assess the impact of diets on the plasma profile [3].
Sulforaphane and obesity-related metabolic dysfunction
Sulforaphane, a bioactive isothiocyanate derived primarily from broccoli and other cruciferous vegetables, has been evaluated in a narrative review for antioxidant, anti-inflammatory and metabolic regulatory properties. Obesity is characterised by adipose tissue dysfunction, insulin resistance, chronic low-grade inflammation, oxidative stress, mitochondrial dysfunction and increased cardiometabolic risk, and the review critically evaluates sulforaphane and broccoli-derived preparations in this context [4].
Aflatoxin B₁ and glucose–lipid metabolism in fat-tailed ewes
In twenty non-pregnant, non-lactating multiparous Ghezel ewes, a control diet was compared with the same basal diet supplemented with aflatoxin B₁-contaminated rice culture providing 500 µg AFB₁/kg dry matter for 40 days. Individual dry matter intake was not measured, but all animals consumed the full daily ration, ensuring uniform nutrient intake. The study evaluated rumen fermentation, hepatic health, oxidative stress, inflammation and glucose–lipid metabolism [5].
Aluminium maltolate and the AMPK–PGC-1α–SIRT3 axis in HT22 cells
Mouse hippocampal neuronal HT22 cells were exposed to aluminium maltolate [Al(mal)₃, 60–240 µM] to investigate alterations in mitochondrial bioenergetics and senescence-associated pathways. Aluminium exposure significantly increased senescence-associated β-galactosidase (SA-β-gal) activity and upregulated p16 and p21 expression, accompanied by G2/M phase arrest [6]. This is an in vitro cell model.
Metformin withdrawal and metabolic flexibility in metabolic syndrome
A clinical trial is investigating how a short-term interruption of metformin treatment affects insulin sensitivity, glucose control and metabolic flexibility in adults with metabolic syndrome who are taking metformin as part of their usual medical treatment. Temporary interruptions may occur in real life, such as missed doses, medication access problems, travel, or planned short-term discontinuation for clinical reasons. The study aims to understand whether stopping metformin for 14 days leads to rapid changes in glucose metabolism or whether the effects of previous metformin treatment persist during a short period without the medication [7].
Sirtuin activators and weight management
Obesity is a chronic, multifactorial disease associated with a high burden of metabolic, cardiovascular and psychosocial complications. Long-term effectiveness of lifestyle-based weight-management strategies remains limited, and there is growing interest in molecular pathways that may enhance metabolic flexibility and improve treatment outcomes. Among these, the sirtuin (SIRT) family—particularly SIRT1 and SIRT3—has emerged as a target due to its involvement in mitochondrial biogenesis, energy expenditure, oxidative metabolism and the regulation of insulin sensitivity. Bioactive compounds that activate sirtuins, including nicotinamide riboside, are under study [8].
Comparison of selected study models
| Study | Model / population | MetFlex-relevant measure |
|---|---|---|
| Extreme obesity study [1] | Adults with BMI ≥60 kg/m² (n=10) | Response to a high-fat test meal; energy expenditure and fat oxidation |
| Grape polyphenol trial [2] | Human participants (whole grapes) | Whole-room indirect calorimetry plus PBMC respirometry |
| Mediterranean diet trial [3] | Adults ≥60 years with MCI (n=47) | Plasma metabolome by targeted LC-MS/MS |
| Aflatoxin B₁ study [5] | Ghezel ewes (n=20) | Rumen fermentation and glucose–lipid metabolism |
| Aluminium maltolate study [6] | HT22 mouse hippocampal cells (in vitro) | Mitochondrial bioenergetics; AMPK–PGC-1α–SIRT3 axis |
If you are reading this for personal health reasons
The materials described here are sold for laboratory research only, and we do not provide dosing or medical guidance. Anyone considering a compound for themselves should speak to a licensed clinician.
Sources
- [1] Evaluating Metabolic Health in Individuals With Extreme Obesity
- [2] Vitis Intervention Trial in Substrate Metabolism
- [3] Enhanced metabolic flexibility links Mediterranean diet with cognition: interim findings from a randomized controlled trial.
- [4] Sulforaphane and Broccoli-Derived Preparations in Obesity and Obesity-Related Metabolic Dysfunction
- [5] Impact of chronic dietary aflatoxin B1 intake on rumen fermentation, hepatic health, oxidative stress, inflammation, and glucose-lipid metabolism in fat-tailed ewes.
- [6] The AMPK-PGC-1α-SIRT3 axis mediates mitochondrial metabolic dysfunction and neuronal senescence induced by Al(mal)3 exposure in HT22 hippocampal neuronal cells.
- [7] Metformin Withdrawal In Metabolic Syndrome
- [8] Sirtuin Activators and Weight Loss
- [9] Mitokines as bioenergetic stress signals in cardiovascular disease
- [10] HACD1-driven long-chain fatty acid metabolic reprogramming enhances esophageal cancer tumorigenicity.